Statistics for Syndax Pharmaceuticals (id:7683 SNDX)

Valuation metrics

Market cap

1.38B

Enterprise value

945.67M

Trailing P/E (ttm)

-5.40

Forward P/E

-4.55

PEG ratio

-4.55

Price/Sales (ttm)

85.94

Price/Book (mrq)

3.76

Enterprise Value/Revenue

59.10

Enterprise Value/EBITDA

-2.94

Overview

Shares outstanding

85.36M

Float

85.02M

Shares short

10.66M

% Held by insiders

0.01%

% Held by institutions

1.07%

Average volume (10 days)

2.99M

Average volume (90 days)

Price summary

52-Week low

15.00

52-Week high

25.34

52-Week change

3.79%

Beta

0.92

50-Day moving average

18.87

200-Day moving average

20.90

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-716.62%

Operational effectiveness

Return on assets

-48.67%

Return on equity

-81.88%

Income statement

Revenue (ttm)

0.20

Revenue per share (ttm)

0.20

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-321,200,992.00

Net income to common (ttm)

-297,062,016.00

Diluted EPS (ttm)

-3.64

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

406.40M

Total cash per share (mrq)

4.76

Total debt (mrq)

854.00K

Total Debt/Equity (mrq)

0.23

Current ratio (mrq)

698.60%

Book value per share (mrq)

4.28

Cash flow

Cash flow statement

-258,864,000.00

Levered free cash flow (LFCF)

-142,710,752.00